Cancer Drug Kinavet No Longer Approved for Use
December 15, 2015
Kinavet-CA1, a daily drug indicated for the treatment of mast cell tumors in dogs, is off the market in the United States at least temporarily because its five-year conditional approval expired. The U.S. Food and Drug Administration reported today that sale of the oral tablets, produced by AB Science of Chatham, N.J., must cease immediately.… Continue reading...